Long non-coding RNA MALAT1 modulate cell migration, proliferation and apoptosis by sponging microRNA-146a to regulate CXCR4 expression in acute myeloid leukemia

References

• Bi L, Sun L, Jin Z, et al. MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia. Oncol Lett. 2018;15(4):5611–5619.
   PubMed Web of Science ®Google Scholar
• Tawfik B, Pardee TS, Isom S, et al. Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML). J Geriatr Oncol. 2016;7(1):24–31.
   PubMed Web of Science ®Google Scholar
• Almeida AM, Ramos F. Acute myeloid leukemia in the older adults. Leuk Res Rep. 2016;6:1–7.
   PubMedGoogle Scholar
• Mambet C, Chivu-Economescu M, Matei L, et al. Murine models based on acute myeloid leukemia-initiating stem cells xenografting. World J Stem Cells. 2018;10(6):57–65.
   PubMed Web of Science ®Google Scholar
• Nobili L, Lionetti M, Neri A. Long non-coding RNAs in normal and malignant hematopoiesis. Oncotarget. 2016;7(31):50666–50681.
   PubMedGoogle Scholar
• Wang L, Zhang H, Lei D. microRNA-146a Promotes Growth of acute leukemia cells by Downregulating Ciliary Neurotrophic Factor Receptor and Activating JAK2/STAT3 Signaling. Yonsei Med J. 2019;60(10):924–934.
   PubMed Web of Science ®Google Scholar
• Garzon R, Volinia S, Liu CG, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008;111(6):3183–3189.
   PubMed Web of Science ®Google Scholar
• Starczynowski DT, Morin R, McPherson A, et al. Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood. 2011;117(2):595–607.
   PubMed Web of Science ®Google Scholar
• Hasani SS, Hashemi M, Eskandari-Nasab E, et al. A functional polymorphism in the miR-146a gene is associated with the risk of childhood acute lymphoblastic leukemia: a preliminary report. Tumour Biol. 2014;35(1):219–225.
   PubMed Web of Science ®Google Scholar
• Moran VA, Perera RJ, Khalil AM. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012;40(14):6391–6400.
   PubMed Web of Science ®Google Scholar
• Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38.
   PubMed Web of Science ®Google Scholar
• Barangi S, Hayes AW, Reiter R, et al. The therapeutic role of long non-coding RNAs in human diseases: A focus on the recent insights into autophagy. Pharmacol Res. 2019;142:22–29.
   PubMed Web of Science ®Google Scholar
• Zhao C, Wang S, Zhao Y, et al. Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p/SMC1A in acute myeloid leukemia. J Cell Physiol. 2019;234(5):6161–6172.
   PubMed Web of Science ®Google Scholar
• Cheng P, Lu P, Guan J, et al. LncRNA KCNQ1OT1 controls cell proliferation, differentiation and apoptosis by sponging miR-326 to regulate c-Myc expression in acute myeloid leukemia. Neoplasma. 2020;67(2):238–248.
   PubMed Web of Science ®Google Scholar
• Wang SL, Huang Y, Su R, et al. Silencing long non-coding RNA HOTAIR exerts anti-oncogenic effect on human acute myeloid leukemia via demethylation of HOXA5 by inhibiting Dnmt3b. Cancer Cell Int. 2019;19:114.
   PubMed Web of Science ®Google Scholar
• Tripathi V, Ellis JD, Shen Z, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010;39(6):925–938.
   PubMed Web of Science ®Google Scholar
• Ronchetti D, Agnelli L, Taiana E, et al. Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma. Oncotarget. 2016;7(12):14814–14830.
   PubMedGoogle Scholar
• Ahmadi A, Kaviani S, Yaghmaie M, et al. Altered expression of MALAT1 lncRNA in chronic lymphocytic leukemia patients, correlation with cytogenetic findings. Blood Res. 2018;53(4):320–324.
   PubMed Web of Science ®Google Scholar
• Wen F, Cao YX, Luo ZY, et al. LncRNA MALAT1 promotes cell proliferation and imatinib resistance by sponging miR-328 in chronic myelogenous leukemia. Biochem Biophys Res Commun. 2018;507(1–4):1–8.
   PubMed Web of Science ®Google Scholar
• Pouyanrad S, Rahgozar S, Ghodousi ES. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia. Gene. 2019;692:35–43.
   PubMed Web of Science ®Google Scholar
• Feng LL, Xin WN, Tian XL. MALAT1 modulates miR-146′s protection of microvascular endothelial cells against LPS-induced NF-kappaB activation and inflammatory injury. Innate Immun. 2019;25(7):433–443.
   PubMed Web of Science ®Google Scholar
• Li H, Xie S, Li H, Zhang R, Zhang H. LncRNA MALAT1 mediates proliferation of LPS treated-articular chondrocytes by targeting the miR-146a-PI3K/Akt/mTOR axis. Life Sci. 2020;1(254):116801.
   Google Scholar
• Tan X, Huang Z, Li X. Long Non-coding RNA MALAT1 Interacts With miR-204 to modulate human Hilar Cholangiocarcinoma proliferation, migration, and invasion by targeting CXCR4. J Cell Biochem. 2017;118(11):3643–3653.
   PubMed Web of Science ®Google Scholar
• Labbaye C, Spinello I, Quaranta MT, et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol. 2008;10(7):788–801.
   PubMed Web of Science ®Google Scholar
• Braess J. [Acute myeloid leukemia]. Dtsch Med Wochenschr. 2016;141(24):1748–1751.
   PubMed Web of Science ®Google Scholar
• Schwarzer A, Emmrich S, Schmidt F, et al. The non-coding RNA landscape of human hematopoiesis and leukemia. Nat Commun. 2017;8(1):218.
   PubMedGoogle Scholar
• <Prediction of competing endogenous RNA coexpression network as prognostic markers in AML.pdf>.
   Google Scholar
• Garzon R, Volinia S, Papaioannou D, et al. Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Proc Natl Acad Sci U S A. 2014;111(52):18679–18684.
   PubMed Web of Science ®Google Scholar
• Yoshimoto R, Mayeda A, Yoshida M, et al. MALAT1 long non-coding RNA in cancer. Biochim Biophys Acta. 2016;1859(1):192–199.
   PubMed Web of Science ®Google Scholar
• Guo F, Guo L, Li Y, et al. MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation. Int J Clin Exp Pathol. 2015;8(12):15903–15910.
   PubMed Web of Science ®Google Scholar
• Arun G, Spector DL. MALAT1 long non-coding RNA and breast cancer. RNA Biol. 2019;16(6):860–863.
   PubMed Web of Science ®Google Scholar
• Si Y, Yang Z, Ge Q, et al. Long non-coding RNA Malat1 activated autophagy, hence promoting cell proliferation and inhibiting apoptosis by sponging miR-101 in colorectal cancer. Cell Mol Biol Lett. 2019;24:50.
   PubMed Web of Science ®Google Scholar
• Sun Y, Ma L. New insights into long Non-coding RNA MALAT1 in cancer and metastasis. Cancers (Basel). 2019;11(2):216.
   PubMed Web of Science ®Google Scholar
• Lu H, He Y, Lin L, et al. Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer via sponging miR-145. Tumour Biol. 2016;37(2):1683–1691.
   PubMedGoogle Scholar
• Zhang Y, Chen Z, Li MJ, et al. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression. Biomed Pharmacother. 2017;85:264–271.
   PubMed Web of Science ®Google Scholar
• Dai L, Zhang G, Cheng Z, et al. Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury. Connect Tissue Res. 2018;59(6):581–592.
   PubMed Web of Science ®Google Scholar